Canadian Product Portfolio English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Divisions
    • Overview
    • Medexus Pharma Canada
    • Medexus Pharma USA
  • Product Portfolio
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR
  • Contact
  • Careers
  • English
  • Français
  • Canadian Product Portfolio

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • 2022 Annual Meeting
    • 2021 Annual Meeting
    • 2020 Annual Meeting
    • 2021 Special Meeting
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • TSX: MDP
    • OTCQX: MEDXF
    • Analyst Coverage
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEDAR
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • 2022 Annual Meeting
  • 2021 Annual Meeting
  • 2020 Annual Meeting
  • 2021 Special Meeting
Nov 04, 2021 8:30am EDT

Medexus Schedules Second Quarter Fiscal 2022 Conference Call

Nov 01, 2021 9:27am EDT

Medexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan

Oct 26, 2021 8:30am EDT

Medexus to Present at the Benzinga Global Small Cap Conference on October 28, 2021

Sep 21, 2021 6:09pm EDT

Medexus Announces Expanded Availability of Trecondyv® (treosulfan) in Canada

Sep 16, 2021 4:30pm EDT

Medexus Holds Annual and Special Meeting of Shareholders and Announces Election of Board of Directors

Sep 02, 2021 8:30am EDT

Medexus Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 16, 2021 5:30pm EDT

Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022

Aug 12, 2021 7:30am EDT

Medexus Completes Enrollment in Phase 4 Clinical Trial of IXINITY® Targeting Label Expansion for Pediatric Hemophilia B Patients

Aug 10, 2021 1:00pm EDT

Medexus Pharmaceuticals to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021

Aug 10, 2021 8:30am EDT

Medexus Schedules First Quarter Fiscal 2022 Conference Call

RSS
  • Previous
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...13
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.